Tech Company Financing Transactions
Precision Immune Funding Round
SV Health Investors and private investors invested in a $8 million capital raise for Precision Immune. The financing closed on 9/30/2016.
Transaction Overview
Company Name
Announced On
9/30/2016
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
953 Indiana St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Overview
Pi develops drugs to perform exceptional fine-tuning of immune responses. This goal addresses a current and justified excitement about immunotherapy and introduces technology to rapidly identify and target novel arms of the immune response, within the tumor microenvironment (TME).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve James
Browse more venture capital transactions:
Prev: 9/30/2016: Planetary Network Technologies venture capital transaction
Next: 9/30/2016: Meq venture capital transaction
Share this article
News on VC Transactions
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs